BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 11376015)

  • 1. Hormone replacement therapy and the endometrium.
    Feeley KM; Wells M
    J Clin Pathol; 2001 Jun; 54(6):435-40. PubMed ID: 11376015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy (HRT) and endometrial morphology under consideration of the different molecular pathways in endometrial carcinogenesis.
    Horn LC; Dietel M; Einenkel J
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):4-12. PubMed ID: 15927347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.
    Sturdee DW; Ulrich LG; Barlow DH; Wells M; Campbell MJ; Vessey MP; Nielsen B; Anderson MC; Bragg AJ
    BJOG; 2000 Nov; 107(11):1392-400. PubMed ID: 11117768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Suckling J; Barlow D; Farquhar CM; Jepson RG; Roberts H
    Cochrane Database Syst Rev; 2004; (3):CD000402. PubMed ID: 15266429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the endometrial effects of estrogens and progestins.
    Creasy GW; Kafrissen ME; Upmalis D
    Obstet Gynecol Surv; 1992 Sep; 47(9):654-78. PubMed ID: 1436909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balancing safety and efficacy focus on endometrial protection.
    Boroditsky RS
    J Reprod Med; 2000 Mar; 45(3 Suppl):273-84. PubMed ID: 10756508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E; Holinka CF; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
    Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
    BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial morphology and bleeding patterns as a function of progestogen supplementation.
    Sturdee DW
    Int J Fertil Menopausal Stud; 1996; 41(1):22-8. PubMed ID: 8673153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hormone therapy on the endometrium.
    Deligdisch L
    Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HRT in post-menopausal women: endometrial histology and bleeding patterns].
    Lo Dico G; Alongi G; Spinelli MP; Cannariato P; Lucido AM
    Minerva Ginecol; 2002 Aug; 54(4):361-6. PubMed ID: 12114870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestagen replacement therapy? UK Continuous Combined HRT Study Investigators.
    Sturdee DW; Barlow DH; Ulrich LG; Wells M; Gydesen H; Campbell M; O'Brien K; Vessey M
    Lancet; 1994 Oct; 344(8928):979-82. PubMed ID: 7934429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of oestrogens and progestogens on the postmenopausal endometrium.
    Whitehead MI
    Maturitas; 1978 Sep; 1(2):87-98. PubMed ID: 755961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial safety of hormone replacement therapy: review of literature.
    Van Gorp T; Neven P
    Maturitas; 2002 Jun; 42(2):93-104. PubMed ID: 12065168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No increased risk of endometrial hyperplasia with fixed long-cycle oestrogen-progestogen therapy after five years.
    Erkkola R; Kumento U; Lehmuskoski S; Mattila L; Mustonen M
    J Br Menopause Soc; 2004 Mar; 10(1):9-13. PubMed ID: 15107205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonographic endometrial monitoring during continuous-sequential hormonal replacement therapy regimen in postmenopausal women.
    Affinito P; Palomba S; Sammartino A; Bonifacio M; Nappi C
    Maturitas; 2001 Sep; 39(3):239-44. PubMed ID: 11574183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound assessment of endometrial thickness and endometrial polyps in women on hormonal replacement therapy.
    Van den Bosch T; Van Schoubroeck D; Ameye L; De Brabanter J; Van Huffel S; Timmerman D
    Am J Obstet Gynecol; 2003 May; 188(5):1249-53. PubMed ID: 12748493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endometrial growth in continuous, estrogen substitution monotherapy with Estraderm TTS (0.05 mg/die) in 31 postmenopausal females].
    Meuwissen JH; van Langen H; Nielen M
    Geburtshilfe Frauenheilkd; 1992 Jun; 52(6):351-4. PubMed ID: 1634098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.